Pharmacopeia Assists The World Health Organization In The Discovery Of Novel Therapeutics For The Treatment Of Malaria

Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that the company will assist the World Health Organization’s Special Program for Research and Training in Tropical Diseases (WHO/TDR) in its efforts to develop novel antimalarial agents. [click link for full article]

More: continued here

Filed under: Tropical on August 29th, 2007